 | Short Interest in Propanc Biopharma, Inc. (OTCMKTS:PPCB) Decreases By 60.1%
americanbankingnews.com - March 28 at 3:22 PM |
 | Propanc Biopharma Provides Upcoming Milestones
finance.yahoo.com - March 25 at 12:39 PM |
| Propanc Biopharma Provides A Shareholder Update for 2021
finance.yahoo.com - March 3 at 12:14 PM |
| Professor Juan Marchal Believes Propanc Biopharma’s Proenzyme Therapy May Offer New Treatment Opportunity for Cancer Patients
finance.yahoo.com - February 15 at 9:36 AM |
| Propanc Biopharma Appoints Belen Toledo to Evaluate Impact of Proenzyme Therapy on Tumor Microenvironment
finance.yahoo.com - January 28 at 2:05 PM |
 | Propanc Biopharma, Inc.: Propanc Biopharma Receives Expression of Interest to Evaluate Proenzyme Therapy in Pancreatic and Ovarian Cancer Patients
finanznachrichten.de - January 19 at 7:02 PM |
| Propanc Biopharma Receives Expression of Interest to Evaluate Proenzyme Therapy in Pancreatic and Ovarian Cancer Patients
finance.yahoo.com - January 19 at 7:02 PM |
| Propanc Biopharma Analyzes Pancreatic Proenzymes Vs T-Cell Therapy Targeting Solid Tumors Such as Pancreatic, Ovarian & Colorectal Cancers
finance.yahoo.com - January 11 at 10:15 AM |
|
| Propanc Biopharma Advances POP1 Joint Research and Drug Discovery Program for Projected US$111.2B Global Metastatic Cancer Market
finance.yahoo.com - December 30 at 1:00 PM |
| Propanc Biopharma Receives First Granted Patent for Method to Treat Cancer Stem Cells from Australian Patent Office
finance.yahoo.com - December 21 at 9:04 AM |
 | Propanc Biopharma Inc (PPCB)
nasdaq.com - October 20 at 7:20 PM |
| Propanc Biopharma, Inc. (PPCB)
ca.finance.yahoo.com - October 17 at 6:47 PM |
 | Propanc Biopharma Inc.
marketwatch.com - September 17 at 8:13 PM |
| Propanc Biopharma Receives Investment from Institutional Investor
finance.yahoo.com - July 28 at 12:46 PM |
| Propanc Biopharma Provides Shareholder Update
finance.yahoo.com - May 11 at 5:57 PM |
| How Propanc Biopharma Is Joining the Fight with Cancer Patients Who Are Increasingly Vulnerable to the COVID-19 Global Pandemic
finance.yahoo.com - April 16 at 11:37 AM |
| Propanc Biopharma Receives First Allowance for Key Patent Family from Australian Patent Office
finance.yahoo.com - April 14 at 3:55 PM |
| Propanc Biopharma Enters Into a $3 Million Financing with Institutional Investor
finance.yahoo.com - March 31 at 12:30 PM |
| Propanc Biopharma's Scientific Advisory Board Member Promoted to Professorship Position at Jaén University, Spain
www.finanznachrichten.de - March 16 at 9:04 AM |
| Propanc Biopharma’s Scientific Advisory Board Member Promoted to Professorship Position at Jaén University, Spain
finance.yahoo.com - March 16 at 9:04 AM |
| Propanc Biopharma Receives Advance Overseas Finding from Innovation and Science Australia
finance.yahoo.com - January 21 at 4:17 PM |
 | Propanc Biopharma nears production of synthetic pancreatic proenzymes
www.proactiveinvestors.com - November 18 at 5:19 PM |
| Propanc Biopharma Advances POP1 Drug Discovery Program
finance.yahoo.com - November 18 at 12:18 PM |
| Propanc Biopharma Provides Shareholder Update and Forecast for 2020
finance.yahoo.com - October 29 at 9:08 AM |
| Propanc Biopharma plans to advance clinical trials on lead cancer drug PRP
www.proactiveinvestors.com - October 21 at 1:58 PM |
| Propanc Biopharma Illustrates Novel Mode of Action of PRP, Suppressing EMT Pathways and Metastasis in Cancer Patients
finance.yahoo.com - October 21 at 8:58 AM |
| Propanc Biopharma Receives Granted US Patent Covering Additional Composition Claims for PRP
finance.yahoo.com - August 21 at 9:43 AM |
| Propanc Biopharma Completes Development of Bio-analytical Assay Method to Quantify PRP’s Active Ingredients in Preparation for First-In-Human Study
finance.yahoo.com - August 8 at 11:37 AM |
|
 | Propanc Biopharma Provides Update on Preparation of PRP for Clinical Trial Application Submission and Recently Completed Reverse Stock Split
markets.businessinsider.com - July 15 at 10:17 AM |
| Propanc Biopharma Appoints Carlo Campiciano as Chief Financial Officer
finance.yahoo.com - July 14 at 9:48 AM |
| Propanc poised to unlock shareholder value as it boosts its patent portfolio for cancer-fighting drugs
www.proactiveinvestors.com.au - June 27 at 5:00 PM |
 | Propanc Biopharma appoints Carlo Campiciano as CFO
seekingalpha.com - June 24 at 6:05 PM |
| Propanc Biopharma files for $10M equity offering
seekingalpha.com - May 23 at 10:02 AM |
| Propanc Biopharma appoints Ralf Brandt to scientific advisory board as it develops cancer patent
www.proactiveinvestors.com - May 15 at 10:06 AM |
| Propanc welcomes founding member back to scientific advisory board
www.proactiveinvestors.com - May 6 at 5:37 PM |
| Propanc Biopharma Appoints Dr. Ralf Brandt to its Scientific Advisory Board
finance.yahoo.com - May 6 at 10:11 AM |
| Propanc looks to history to capitalize on glimmering angle in cancer treatment
www.proactiveinvestors.com - April 18 at 10:47 AM |
| Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials
finance.yahoo.com - March 25 at 10:03 AM |
 | Propanc Biopharma Inc
www.bloomberg.com - March 18 at 5:52 PM |
| Propanc Biopharma Receives Notice of Allowance for Additional Claims from Foundation Patent in the U.S.
finance.yahoo.com - March 13 at 9:15 AM |
| Propanc Biopharma to Present at the 31st Annual ROTH Conference March 17 – 19, 2019
finance.yahoo.com - March 5 at 10:44 AM |
| Propanc Biopharma to Present at the 2019 BIO CEO & Investor Conference
finance.yahoo.com - January 29 at 10:06 AM |
| Propanc Biopharma Commences Drug Discovery Research Collaboration
finance.yahoo.com - January 2 at 9:47 AM |
| Propanc Biopharma’s Foundation Patent Granted in India
finance.yahoo.com - December 20 at 10:03 AM |
 | Propanc Tags LHS to Get Word out, Shares Pop
www.baystreet.ca - December 18 at 4:22 PM |
| Propanc Biopharma Selects LaVoieHealthScience as Integrated Communications Partner
finance.yahoo.com - December 18 at 9:58 AM |
